CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
April 2021—nRichDX launched its Revolution Semi-Automated Workflow powered by Eppendorf’s epMotion 5073 instrument for the extraction of cfDNA and ctDNA from plasma and urine for liquid-based assay development. The semiautomated workflow automates the Revolution protocol’s wash and elution steps and is designed to increase yield, sensitivity, and throughput.
The system enables extraction from batches of eight to 24 samples in as little as three hours with 20 minutes of hands-on time. Sample volumes range from 3 mL to 20 mL and recovery rates are 70 to 90 percent.
The semiautomated workflow is not labeled for IVD use, despite the fact, the company says, that the Revolution cfDNA isolation kits are labeled for IVD use.
Pages: 1 2